Crews hit the road this week to begin creating a database of conditions at culverts, bridges, dams, weirs and other manmade structures in Northwest Indiana streams. Their information will help the ...

A new report on a fiery train derailment in North Dakota points to deteriorating culverts below the tracks and poor-quality inspections by the railroad operator. The July 2024 derailment of a Canadian ...

Browse projects, edit plans, run simulations, load flood results, extract flow hydrographs, and animate time steps — all inside QGIS, without opening HEC-RAS.

UVM students help clear leaves from a culvert as part of the Culvert Crawlers program. Photo courtesy Charis Boke A tube of corrugated metal running under a road might not look like much. But when the ...

This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.

EAU CLAIRE COUNTY, Wis. (WEAU) - The Eau Claire County Highway Department is announcing County Highway D in the Town of Clear Creek will be closed for multiple culvert removals and replacements. A map ...

CUMMINGTON — Bill Adams looks out onto what once was an artificially formed pond on Stage Road in Cummington. For years, a small culvert prevented full water flow from the North Branch Swift River, a ...

EAU CLAIRE COUNTY, Wis. (WEAU) - The Eau Claire County Highway Department is announcing that CTH U in the Town of Clear Creek and Town of Pleasant Valley will be closed for multiple culvert removals ...

EAU CLAIRE COUNTY, Wis. (WEAU) - Eau Claire County is informing the public of an expected road closure. According to a press release from Eau Claire County, County Highway WW (Buffalo County Line to ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted ...